Pemphigoid nodularis: Difference between revisions
CSV import |
CSV import Tag: Reverted |
||
| Line 34: | Line 34: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Revision as of 22:39, 17 March 2025
Pemphigoid nodularis is a rare variant of Bullous pemphigoid, a chronic autoimmune skin disease. It is characterized by the presence of nodular lesions, in addition to the typical blistering lesions seen in bullous pemphigoid.
Clinical Features
Patients with pemphigoid nodularis present with pruritic, nodular lesions that may be accompanied by vesicles or bullae. The nodules are typically firm and may be located anywhere on the body, but are most commonly found on the extremities. The vesicles or bullae are usually tense and filled with clear fluid.
Pathogenesis
The pathogenesis of pemphigoid nodularis is not fully understood. It is thought to be an autoimmune disease, with autoantibodies targeting the basement membrane zone of the skin. This leads to inflammation and the formation of blisters.
Diagnosis
Diagnosis of pemphigoid nodularis is based on clinical features, histopathological examination, and immunofluorescence studies. Histopathology typically shows a subepidermal blister with a dense eosinophilic infiltrate. Direct immunofluorescence shows linear deposition of IgG and C3 along the basement membrane zone.
Treatment
Treatment of pemphigoid nodularis involves the use of systemic corticosteroids and immunosuppressive agents. Topical corticosteroids may also be used for localized disease.
Prognosis
The prognosis of pemphigoid nodularis is generally good with treatment. However, the disease tends to be chronic and may require long-term management.
See Also
References
<references />


